- Home
- NAMS vs HOG Comparison
NAMS vs HOG Comparison
Compare NAMS & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- HOG
- Stock Information
- Founded
- NAMS 2019
- HOG 1903
- Country
- NAMS Netherlands
- HOG United States
- Employees
- NAMS N/A
- HOG N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- HOG Motor Vehicles
- Sector
- NAMS Health Care
- HOG Consumer Discretionary
- Exchange
- NAMS Nasdaq
- HOG Nasdaq
- Market Cap
- NAMS 2.9B
- HOG 2.8B
- IPO Year
- NAMS N/A
- HOG N/A
- Fundamental
- Price
- NAMS $25.07
- HOG $27.41
- Analyst Decision
- NAMS Strong Buy
- HOG Buy
- Analyst Count
- NAMS 9
- HOG 6
- Target Price
- NAMS $41.00
- HOG $29.33
- AVG Volume (30 Days)
- NAMS 843.1K
- HOG 2.7M
- Earning Date
- NAMS 08-06-2025
- HOG 07-30-2025
- Dividend Yield
- NAMS N/A
- HOG 2.61%
- EPS Growth
- NAMS N/A
- HOG N/A
- EPS
- NAMS N/A
- HOG 1.93
- Revenue
- NAMS $64,006,000.00
- HOG $4,474,610,000.00
- Revenue This Year
- NAMS N/A
- HOG N/A
- Revenue Next Year
- NAMS $73.09
- HOG $4.22
- P/E Ratio
- NAMS N/A
- HOG $14.23
- Revenue Growth
- NAMS 762.15
- HOG N/A
- 52 Week Low
- NAMS $14.06
- HOG $20.45
- 52 Week High
- NAMS $27.29
- HOG $39.93
- Technical
- Relative Strength Index (RSI)
- NAMS 61.96
- HOG 65.55
- Support Level
- NAMS $24.73
- HOG $23.92
- Resistance Level
- NAMS $25.80
- HOG $24.60
- Average True Range (ATR)
- NAMS 1.33
- HOG 1.22
- MACD
- NAMS 0.17
- HOG 0.39
- Stochastic Oscillator
- NAMS 83.46
- HOG 80.00
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.